Trevena Inc. buy melinda
Start price
20.02.17
/
50%
€110.27
Target price
21.08.17
€180.40
Performance (%)
-52.15%
End price
21.08.17
€52.77
Summary
This prediction ended on 21.08.17 with a price of €52.77. Massive losses of -52.15% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Trevena Inc. | - | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by melinda for this prediction
In the thread Trevena Inc. diskutieren
Trevena, Inc. ist ein biopharmazeutisches company.It entdeckt, entwickelt
(Laufzeit überschritten)